Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

IMUX Immunic Inc

-0.035 (-2.73%)
Last Updated: 15:04:09
Delayed by 15 minutes


Draw Mode:

Volume 88,639
Bid Price 1.24
Ask Price 1.25
News -
Day High 1.28


52 Week Range


Day Low 1.245
Company Name Stock Ticker Symbol Market Type
Immunic Inc IMUX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.035 -2.73% 1.245 15:04:09
Open Price Low Price High Price Close Price Prev Close
1.27 1.245 1.28 1.28
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
624 88,639 $ 1.26 $ 111,744 - 0.9451 - 3.11
Last Trade Time Type Quantity Stock Price Currency
15:08:26 2 $ 1.245 USD

Immunic Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
112.41M 89.93M - 0 -93.61M -1.04 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Immunic News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No IMUX Message Board. Create One! See More Posts on IMUX Message Board See More Message Board Posts

Historical IMUX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.301.341.181.25434,621-0.055-4.23%
1 Month1.2211.441.181.27241,2580.0241.97%
3 Months1.401.641.171.34366,261-0.155-11.07%
6 Months1.041.731.0351.32640,1410.20519.71%
1 Year1.953.110.94511.61769,845-0.705-36.15%
3 Years13.4015.120.94514.26845,065-12.16-90.71%
5 Years9.0328.21380.94515.98591,840-7.79-86.21%

Immunic Description

Immunic Inc is a clinical stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing remitting multiple sclerosis, and psoriasis. The company is developing three small molecule products, IMU-838 is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH, IMU-935 is an inverse agonist of RORyt and IMU-856 targets the restoration of the intestinal barrier function.

Your Recent History

Delayed Upgrade Clock